Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
 

 

Northern New England Node


The Northern New England Node is a partnership between clinical addiction researchers at Harvard Medical School, other universities, and CTPs located in five New England states – Maine, Massachusetts, Rhode Island, New Hampshire, and Vermont. Together, the CTPs had over 48,000 admissions in 2001 for substance use disorders. The CTPs provide services to an ethnically diverse patient population with a variety of substance use disorders in rural, suburban, and urban locales. Special populations include individuals with comorbid psychiatric and medical illnesses, HIV-infected individuals, adolescents, pregnant women, and individuals involved with the criminal justice system.

 

Regional Research and Training Center

McLean Hospital
115 Mill Street
Belmont, MA 02478-9106

 

Principal Investigator

Roger D. Weiss, M.D.
Associate Professor
Department of Psychiatry
Harvard Medical School
Alcohol and Drug Abuse Treatment Program
McLean Hospital
115 Mill Street
Belmont, MA 02478-9106
617-855-2242 (Voice)
rweiss@mclean.harvard.edu

Community Treatment Programs

AdCare Hospital
Worcester, MA

CAB Health and Recovery Services, Inc.
Danvers, MA

Faulkner Hospital
Jamaica Plain, MA

Mercy Hospital
Westbrook, ME

MGH Pediatric Psychopharmacology Research Unit
Boston, MA

Phoenix House Substance Abuse Prevention Corps of Vermont-Americorps
Waterbury, VT

Southeastern New Hampshire Services
Dover, NH

SSTAR of Massachusetts
Fall River, MA

SSTAR of Rhode Island
North Kingstown, RI


Northern New England Protocol Involvement
PROTOCOL0008 A Baseline for Investigating Diffusion of Innovation
PROTOCOL0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Heroin Addicted Adolescents/Young Adults
PROTOCOL0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
PROTOCOL0016 Patient Feedback : A Performance Improvement Study in Outpatient Addiction Treatment
PROTOCOL0017 HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings
PROTOCOL0020 Job-Seekers Training for Patients with Drug Dependence
PROTOCOL0028 Osmotic-Release Methylphenidate for ADHD in Adolescents with Substance Use Disorders
PROTOCOL0029 A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD
PROTOCOL0030 Prescription Opioid treatment Study (POATS)



 

 



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Monday, July 14, 2008. The U.S. government's official web portal